Diploma PLC (LON:DPLM – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is GBX 6,251.25.
DPLM has been the topic of a number of analyst reports. Deutsche Bank Aktiengesellschaft lifted their price objective on Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a report on Thursday, March 19th. Shore Capital Group reissued a “hold” rating on shares of Diploma in a research note on Wednesday, March 18th. JPMorgan Chase & Co. raised their price target on Diploma from GBX 5,120 to GBX 5,760 and gave the company a “neutral” rating in a report on Friday, March 27th. Peel Hunt restated a “buy” rating and issued a GBX 6,150 price target on shares of Diploma in a research note on Friday, December 19th. Finally, Royal Bank Of Canada upped their price objective on Diploma from GBX 6,200 to GBX 6,600 and gave the stock an “outperform” rating in a report on Thursday, March 19th.
View Our Latest Research Report on Diploma
Insiders Place Their Bets
Diploma Trading Up 2.1%
Shares of Diploma stock opened at GBX 6,090 on Friday. Diploma has a 52-week low of GBX 3,532 and a 52-week high of GBX 6,105. The company has a quick ratio of 0.80, a current ratio of 2.04 and a debt-to-equity ratio of 46.97. The company’s 50-day simple moving average is GBX 5,500.77 and its 200-day simple moving average is GBX 5,447.78. The firm has a market cap of £8.17 billion, a price-to-earnings ratio of 44.36, a price-to-earnings-growth ratio of 2.82 and a beta of 1.03.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
